NFKB1 and lung carcinoma: The abnormal expression of nuclear factor kappa B (NF-κb) is correlated with chemoresistance and radio-resistance in lung cancer therapy, and the inhibition of NF-κβ signaling pathway will decrease the resistance given by chemotherapy and radiotherapy (65).